Summary
The Norwegian Gene Technology Act came into force on 1 September 1993. It is an implementation of the EU directives EEC90/219 (Contained use) and EEC90/220 (Deliberate release) according to the economic agreement between Norway and EU (EEA). The directive on deliberate release has since been replaced by a new directive, EU/1829/2003. The main difference between the old directive and this new one from 2003 is that EU has placed a limit for content of GM traces in products and that if the product contains more than 2% of a genetically modified ingredient, the product must be labelled that it contains GMO.